Activity of two polyene and two imidazole antimicrobics on Candida albicans in human fibrin clots

Related Experiment Videos

Insights

Antifungal drugs were tested against Candida albicans in simulated infective fungal endocarditis. Amphotericin B (AMB) and dAb showed antifungal activity, while imidazoles were ineffective.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Infective fungal endocarditis is a severe condition often caused by Candida species.
  • Fungal vegetations on heart valves pose a significant treatment challenge.
  • Evaluating antifungal efficacy within a simulated vegetation model is crucial.

Purpose of the Study:

  • To assess the in vitro efficacy of four antifungal agents against Candida albicans within simulated human fibrin clots.
  • To compare the activity of polyenes (Amphotericin B, dAb) and imidazoles (miconazole, ketoconazole) in this model.

Main Methods:

  • Human fibrin clots inoculated with Candida albicans (10^5 CFU/clot) were prepared.
  • Clots were incubated in human serum with varying concentrations of Amphotericin B, dAb, miconazole, or ketoconazole for 4 days.
  • Clots were serially transferred to fresh drug-containing serum every 12 hours.
  • Quantitative cultures were performed every 24 hours to determine Colony Forming Units (CFU/clot).

Main Results:

  • Imidazole antifungals (miconazole, ketoconazole) did not significantly inhibit Candida albicans growth compared to controls.
  • Both polyene antifungals, Amphotericin B (AMB) and dAb, reduced CFU/clot.
  • Amphotericin B demonstrated significantly greater antifungal activity than dAb in this model.

Conclusions:

  • Polyene antifungals are more effective than imidazoles against Candida albicans in a simulated fungal endocarditis vegetation model.
  • Amphotericin B exhibits superior efficacy compared to dAb in reducing fungal burden within the simulated vegetations.

Related Concept Videos